{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-017174","form_type":"8-K","ticker":"AXSM","cik":"0001579428","company_name":"Axsome Therapeutics, Inc.","filed_at":"2024-02-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.686493+00:00","generated_at":"2026-06-05T23:04:49.472541+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Axsome Therapeutics updates corporate presentation on February 20, 2024","bullets":["Company posted updated corporate presentation to its website on February 20, 2024.","Presentation filed as Exhibit 99.1; specific content not available in filing text.","No financial results, clinical updates, or guidance changes disclosed in the 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-017174","json":"https://secwatch.observer/filing/0000950170-24-017174.json","markdown":"https://secwatch.observer/filing/0000950170-24-017174.md","text":"https://secwatch.observer/filing/0000950170-24-017174.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1579428/000095017024017174/0000950170-24-017174-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1579428/000095017024017174/axsm-20240220.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T23:04:49.472541+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}